Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S
about
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesVitamin B and its derivatives for diabetic kidney diseaseIntensive glucose control versus conventional glucose control for type 1 diabetes mellitusVitamin B and/or its derivatives for diabetic kidney diseaseRedox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and PodocytesBiomarkers in diabetes: hemoglobin A1c, vascular and tissue markersSimple non-invasive assessment of advanced glycation endproduct accumulationAdvanced glycation end-product accumulation and associated protein modification in type II skeletal muscle with agingRAGE-dependent activation of gene expression of superoxide dismutase and vanins by AGE-rich extracts in mice cardiac tissue and murine cardiac fibroblasts.Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.Emerging drugs for diabetic retinopathy.Biomarkers in Diabetic RetinopathyPartial characterization of the molecular nature of collagen-linked fluorescence: role of diabetes and end-stage renal disease.Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease.Musculoskeletal complications in type 1 diabetes.Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescenceSkin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes.Anaerobic vs aerobic pathways of carbonyl and oxidant stress in human lens and skin during aging and in diabetes: A comparative analysisNew-onset ichthyosis and diabetes in a 14-year-old.Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.Skin intrinsic fluorescence correlates with autonomic and distal symmetrical polyneuropathy in individuals with type 1 diabetesSkin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.Neurovascular disease, antioxidants and glycation in diabetes.Skin intrinsic fluorescence is associated with hemoglobin A(1c )and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes.Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications StudyIntensive diabetes therapy and ocular surgery in type 1 diabetes.Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease.Skin Autofluorescence Is Associated with Endothelial Dysfunction in Uremic Subjects on Hemodialysis.Women, type 2 diabetes, and fracture risk.Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes.Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort studyCorrelation of advanced glycation endproducts estimated from skin fluorescence in first-degree relatives: the impact of adjustment for skin pigmentationContinuous Glucose Monitoring Systems: A Review.Musculoskeletal manifestations in diabetic patients at a tertiary center.AGEs and glucose levels modulate type I and III procollagen mRNA synthesis in dermal fibroblasts cells cultureDiabetes mellitus and periodontal diseases.Antiglycation Activity of Iridoids and Their Food Sources
P2860
Q22250887-C7DA9238-8172-4FA0-B82A-98C3D530F56DQ24186641-553C8122-35B8-45EF-AE37-9CC95232D0EFQ24200376-3C488311-F4E9-4DB9-A321-31DB1597C1FDQ24236375-26FFF307-1FDF-4CC3-91B9-F1879C4A0815Q26778527-B8BBCE66-96F4-4AD4-BD2F-BA85F35E0747Q26996480-ACEDD28D-23F4-4E05-8E6C-DE2F1DF450A2Q28271097-84720041-4121-4330-B00C-BE0C8EB1E068Q28569771-5E66650D-E21E-4241-ADCE-C0E432F46C0DQ30318035-147006FB-34C0-4F4F-8202-935A82B5B6C8Q30426632-040450F2-9A8E-4687-A393-A49DF829AD6CQ30837772-14DEFEB8-6B9F-4C53-B940-35A76DE38B20Q33388498-DBDAA7F7-B977-40D3-9C26-7F09C4B8460BQ33583030-075D1B95-2FF1-4647-8259-95DA42434C31Q33615419-244C7DE0-9A32-456A-B9BA-215B7281EC8CQ33633674-69B689AC-6E9D-4F3E-8580-6624760F9496Q33793824-F4F27998-0F73-4A6A-BAF8-3891E534482BQ33803493-BD82FCF9-7457-492F-A4DD-1386E020AFBFQ33839324-C24508C1-CF28-4278-BA56-7A32AE10E5EFQ33905029-665AA337-3C9C-4B5B-8D43-E278202101FAQ34023341-55506B84-A2A8-4179-B2FB-8854B68483A9Q34113826-043CBE66-B7CF-471A-A0F7-ABE2C5DCF3C5Q34527201-D2BAFA00-7DF4-4C68-AAF6-C12F7D110792Q34718237-D5BDED20-0A75-41B6-B169-75F5B61B0DC1Q34762475-905D3BF9-D4D2-4B46-9320-E554885DAF42Q34804227-36A6D728-BEF6-45B9-A22F-248136244BC2Q35123432-CE4442E0-0099-4CC3-8207-943B9038AD11Q35596137-3906DDD4-AF8E-4844-8DD9-87EF4F7F4C7AQ35734567-B50A4FE8-54CD-468C-B141-6039DD761538Q35783715-466BE5C1-6BF7-4D93-BC30-49C66BC16A00Q35904085-5B195A25-36B5-4FC7-84A7-A823485281BBQ35907238-BB60A5B7-D584-4BE3-B87A-0CA2CD4AE3D4Q35976587-B94B8477-A37F-49C8-A8A9-96B27CDE623FQ36030387-9F31DCF8-112E-4DA8-88AF-0748EC4A0CBCQ36128952-F81EE9A4-C626-4212-A15C-F08552CC3D2AQ36159140-D1B8EAC0-5F7C-4A91-8B4C-10717DAA0F6DQ36335124-C70DE282-C87B-4D10-B1B8-6868AD32BF2EQ36356689-AB2C40BF-3068-406A-83D5-D91CECC752A0Q36528881-066AB85A-2FD2-4595-9361-5AEA81347A40Q36553573-8A6D1F6B-9445-44FE-8270-B457D509BB3FQ36556750-B84EBD7A-AEB0-4D71-95B8-63858857DDBE
P2860
Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Skin collagen glycation, glyco ...... diabetic complications. DCCT S
@ast
Skin collagen glycation, glyco ...... diabetic complications. DCCT S
@en
type
label
Skin collagen glycation, glyco ...... diabetic complications. DCCT S
@ast
Skin collagen glycation, glyco ...... diabetic complications. DCCT S
@en
prefLabel
Skin collagen glycation, glyco ...... diabetic complications. DCCT S
@ast
Skin collagen glycation, glyco ...... diabetic complications. DCCT S
@en
P2093
P2860
P1433
P1476
Skin collagen glycation, glyco ...... diabetic complications. DCCT S
@en
P2093
O Bautista
P A Cleary
V M Monnier
P2860
P304
P356
10.2337/DIABETES.48.4.870
P407
P577
1999-04-01T00:00:00Z